News & Updates
Showing Oncology articles
Showing
Show Multimedia Only

Direct-acting antivirals improve survival in patients with HCV-related HCC
22 Jun 2026
byStephen Padilla
A recent study in UK has shown a significant proportion of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) initiating direct-acting antiviral (DAA) therapy, resulting in improvements in sustained virological response (SVR) rates.
22 Jun 2026

Reduced RT plus chemo-immunotherapy feasible in older/frail NSCLC patients
18 Jun 2026
byStephen Padilla
In older or frail patients with stage III non-small cell lung cancer (NSCLC), undergoing reduced radiotherapy (RT) followed by sequential chemo-immunotherapy results in survival outcomes similar to standard RT, indicating its utility in vulnerable populations, suggests a study.
18 Jun 2026







![[Infographics] STRIDE vs atezolizumab + bevacizumab in 1L HCC – is there any difference in OS](https://cdn.mspprd.mims.com/images/articles/hk-ast-650mo00-9239e16c-91b2-466f-8ff2-e0970d61f9fd-square.jpg)